Key Record Dates
ClinicalTrials.gov Identifier: | NCT04495010 |
---|---|
Brief Title: | Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants (CheckMate 7UA) |
First Submitted : | July 30, 2020 |
First Submitted that Met QC Criteria : | July 30, 2020 |
First Posted : | July 31, 2020 |
Last Update Submitted that Met QC Criteria : | July 30, 2020 |
Last Update Posted : | July 31, 2020 |